tiprankstipranks
AFT Pharmaceuticals Ltd. (AU:AFP)
ASX:AFP
Australian Market
AFP
AFT Pharmaceuticals Ltd.
RESEARCH TOOLSreports

AFT Pharmaceuticals Ltd. (AFP) Ratios

6 Followers

AFT Pharmaceuticals Ltd. Ratios

AU:AFP's free cash flow for Q4 2026 was $0.44. For the 2026 fiscal year, AU:AFP's free cash flow was decreased by $ and operating cash flow was $0.14. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 2.24 2.24 2.50 2.30 2.38
Quick Ratio
 1.12 1.12 1.38 1.23 1.31
Cash Ratio
 0.15 0.15 0.26 0.26 0.12
Solvency Ratio
 0.17 0.17 0.20 0.23 0.17
Operating Cash Flow Ratio
 -0.18 -0.18 0.30 0.63 0.29
Short-Term Operating Cash Flow Coverage
 -0.94 -0.94 12.17 0.00 4.73
Net Current Asset Value
$ 40.60M$ 40.60M$ 35.60M$ 28.27M$ 19.80M
Leverage Ratios
Debt-to-Assets Ratio
 0.25 0.25 0.18 0.19 0.26
Debt-to-Equity Ratio
 0.49 0.49 0.31 0.37 0.52
Debt-to-Capital Ratio
 0.33 0.33 0.24 0.27 0.34
Long-Term Debt-to-Capital Ratio
 0.26 0.26 0.21 0.24 0.31
Financial Leverage Ratio
 1.97 1.97 1.74 1.88 2.02
Debt Service Coverage Ratio
 1.40 1.38 4.33 5.78 2.86
Interest Coverage Ratio
 10.00 9.98 4.15 5.51 6.85
Debt to Market Cap
 0.12 0.15 0.09 0.08 0.10
Interest Debt Per Share
 0.54 0.54 0.31 0.34 0.39
Net Debt to EBITDA
 1.52 1.54 0.88 0.73 1.63
Profitability Margins
Gross Profit Margin
43.40%43.40%43.40%44.78%46.59%
EBIT Margin
9.87%9.76%9.18%13.25%11.92%
EBITDA Margin
11.33%11.21%10.47%14.29%13.02%
Operating Profit Margin
9.76%9.76%5.69%10.47%12.56%
Pretax Profit Margin
8.59%8.59%7.80%11.35%10.09%
Net Profit Margin
5.78%5.78%5.82%8.04%6.80%
Continuous Operations Profit Margin
5.53%5.53%5.55%8.04%6.80%
Net Income Per EBT
67.34%67.34%74.60%70.89%67.43%
EBT Per EBIT
88.01%88.01%137.05%108.38%80.32%
Return on Assets (ROA)
6.79%6.79%7.04%9.45%7.20%
Return on Equity (ROE)
14.07%13.36%12.25%17.78%14.54%
Return on Capital Employed (ROCE)
16.50%16.50%9.24%17.05%18.16%
Return on Invested Capital (ROIC)
9.80%9.80%6.48%12.00%17.14%
Return on Tangible Assets
9.65%9.65%10.72%10.49%8.08%
Earnings Yield
3.55%4.18%4.24%4.56%2.97%
Efficiency Ratios
Receivables Turnover
 3.97 3.97 4.76 4.73 3.95
Payables Turnover
 3.68 4.87 4.63 4.23 3.77
Inventory Turnover
 1.95 1.95 2.40 2.18 1.97
Fixed Asset Turnover
 75.76 75.76 63.23 50.78 46.55
Asset Turnover
 1.17 1.17 1.21 1.17 1.06
Working Capital Turnover Ratio
 4.30 3.46 3.29 3.39 3.03
Cash Conversion Cycle
 180.29 204.66 150.04 157.97 180.50
Days of Sales Outstanding
 92.05 92.05 76.73 77.14 92.32
Days of Inventory Outstanding
 187.54 187.54 152.13 167.13 184.98
Days of Payables Outstanding
 99.30 74.93 78.82 86.29 96.79
Operating Cycle
 279.59 279.59 228.85 244.26 277.29
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.11 -0.11 0.13 0.28 0.11
Free Cash Flow Per Share
 -0.11 -0.11 0.06 0.18 0.11
CapEx Per Share
 <0.01 <0.01 0.07 0.09 <0.01
Free Cash Flow to Operating Cash Flow
 1.01 1.01 0.47 0.67 0.98
Dividend Paid and CapEx Coverage Ratio
 -5.87 -5.87 1.53 2.70 59.03
Capital Expenditure Coverage Ratio
 -101.29 -101.29 1.90 3.03 59.03
Operating Cash Flow Coverage Ratio
 -0.22 -0.22 0.44 0.90 0.31
Operating Cash Flow to Sales Ratio
 -0.05 -0.05 0.06 0.15 0.07
Free Cash Flow Yield
-2.86%-3.37%2.21%5.64%3.19%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 27.98 23.92 23.58 21.95 33.64
Price-to-Sales (P/S) Ratio
 1.62 1.38 1.37 1.77 2.29
Price-to-Book (P/B) Ratio
 3.74 3.19 2.89 3.90 4.89
Price-to-Free Cash Flow (P/FCF) Ratio
 -34.73 -29.69 45.32 17.72 31.35
Price-to-Operating Cash Flow Ratio
 -35.07 -29.99 21.41 11.87 30.82
Price-to-Earnings Growth (PEG) Ratio
 1.03 0.88 -0.88 0.44 -0.71
Price-to-Fair Value
 3.74 3.19 2.89 3.90 4.89
Enterprise Value Multiple
 15.81 13.88 13.98 13.09 19.21
Enterprise Value
 459.14M 396.22M 300.98M 362.81M 391.74M
EV to EBITDA
 15.92 13.88 13.98 13.09 19.21
EV to Sales
 1.80 1.56 1.46 1.87 2.50
EV to Free Cash Flow
 -38.69 -33.39 48.35 18.77 34.27
EV to Operating Cash Flow
 -39.08 -33.72 22.84 12.57 33.69
Tangible Book Value Per Share
 0.43 0.43 0.37 0.68 0.54
Shareholders’ Equity Per Share
 1.05 1.05 0.93 0.84 0.70
Tax and Other Ratios
Effective Tax Rate
 0.36 0.36 0.29 0.29 0.33
Revenue Per Share
 2.43 2.43 1.96 1.85 1.49
Net Income Per Share
 0.14 0.14 0.11 0.15 0.10
Tax Burden
 0.67 0.67 0.75 0.71 0.67
Interest Burden
 0.87 0.88 0.85 0.86 0.85
Research & Development to Revenue
 0.04 0.04 0.06 0.04 0.04
SG&A to Revenue
 0.29 0.29 0.31 0.06 0.07
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 <0.01 0.00
Income Quality
 -0.80 -0.80 0.00 1.85 1.09
Currency in NZD